Does INOTUZUMAB OZOGAMICIN Cause Progressive multifocal leukoencephalopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Progressive multifocal leukoencephalopathy have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 0.2% of all adverse event reports for INOTUZUMAB OZOGAMICIN.
5
Reports of Progressive multifocal leukoencephalopathy with INOTUZUMAB OZOGAMICIN
0.2%
of all INOTUZUMAB OZOGAMICIN reports
4
Deaths
1
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From INOTUZUMAB OZOGAMICIN?
Of the 5 reports, 4 (80.0%) resulted in death, 1 (20.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INOTUZUMAB OZOGAMICIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?
Death (253)
Febrile neutropenia (230)
Venoocclusive liver disease (229)
Neoplasm progression (158)
Pyrexia (151)
Off label use (146)
Sepsis (119)
Venoocclusive disease (109)
Thrombocytopenia (108)
Platelet count decreased (107)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
INOTUZUMAB OZOGAMICIN vs INSULIN
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART
INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTUZUMAB OZOGAMICIN vs INSULIN BEEF
INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC